Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romidepsin in Metastatic Prostate Cancer
NCT00106418Phase 2Completed
- Sponsor
- Celgene Corporation
- Start
- May 2003
- Primary completion
- Sep 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of romidepsin in Metastatic Prostate Cancer (mPC), sponsored by Celgene Corporation. Started May 2003; status: completed.
02
Drugs
romidepsin
03
Conditions
Metastatic Prostate Cancer (mPC)
Beyond the preview
Go deeper on NCT00106418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00106418.